Advanced search
Add to list

Current developments in drug testing in oral fluid

Kristof Pil (UGent) and Alain Verstraete (UGent)
(2008) THERAPEUTIC DRUG MONITORING. 30(2). p.196-202
Author
Organization
Abstract
In the last few years, significant developments have occur-red on the key issues involved in oral fluid drug testing. New pharmacokinetic studies have been conducted, optimal cutoffs have been proposed, and new studies have examined the correlation between oral fluid drug concentrations and impairment. Recent studies (eg, the discovery of the presence of THC-COOH in oral fluid) can contribute to solve the issue of false-positive results caused by passive exposure to marijuana. Reliable point-of-care drug testing is still problematic, especially for cannabinoids and benzodiazepines. To date, there is no device that allows both reliable and practical point-of-care testing. The importance of liquid chromatography- tandem mass spectrometry in confirmation analysis has increased over the last several years. It can be expected that this trend will continue because the low sample volumes make simultaneous detection of different drug classes with limited sample preparation necessary. Literature on proficiency testing to ensure reliability and comparability of results is limited. Oral fluid has become an important sample type in driving under the influence research, and the first legal random drug testing program in oral fluid since 2004 has been organized in Victoria. It can be expected that the role of oral fluid as an alternative matrix will keep increasing in the future.
Keywords
IMPAIRMENT SYMPTOMS, QUANTITATIVE-ANALYSIS, ENANTIOSELECTIVE MEASUREMENT, DELTA(9)-TETRAHYDROCANNABINOL THC, WHOLE-BLOOD, ILLICIT DRUGS, COLLECTION DEVICE, SOLID-PHASE EXTRACTION, METABOLITE 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID, liquid chromatography, TANDEM MASS-SPECTROMETRY, high-pressure, narcotics, saliva, automobile driving

Citation

Please use this url to cite or link to this publication:

MLA
Pil, Kristof, and Alain Verstraete. “Current Developments in Drug Testing in Oral Fluid.” THERAPEUTIC DRUG MONITORING, vol. 30, no. 2, LIPPINCOTT WILLIAMS & WILKINS, 2008, pp. 196–202.
APA
Pil, K., & Verstraete, A. (2008). Current developments in drug testing in oral fluid. THERAPEUTIC DRUG MONITORING, 30(2), 196–202.
Chicago author-date
Pil, Kristof, and Alain Verstraete. 2008. “Current Developments in Drug Testing in Oral Fluid.” THERAPEUTIC DRUG MONITORING 30 (2): 196–202.
Chicago author-date (all authors)
Pil, Kristof, and Alain Verstraete. 2008. “Current Developments in Drug Testing in Oral Fluid.” THERAPEUTIC DRUG MONITORING 30 (2): 196–202.
Vancouver
1.
Pil K, Verstraete A. Current developments in drug testing in oral fluid. THERAPEUTIC DRUG MONITORING. 2008;30(2):196–202.
IEEE
[1]
K. Pil and A. Verstraete, “Current developments in drug testing in oral fluid,” THERAPEUTIC DRUG MONITORING, vol. 30, no. 2, pp. 196–202, 2008.
@article{601776,
  abstract     = {{In the last few years, significant developments have occur-red on the key issues involved in oral fluid drug testing. New pharmacokinetic studies have been conducted, optimal cutoffs have been proposed, and new studies have examined the correlation between oral fluid drug concentrations and impairment. Recent studies (eg, the discovery of the presence of THC-COOH in oral fluid) can contribute to solve the issue of false-positive results caused by passive exposure to marijuana.

Reliable point-of-care drug testing is still problematic, especially for cannabinoids and benzodiazepines. To date, there is no device that allows both reliable and practical point-of-care testing.

The importance of liquid chromatography- tandem mass spectrometry in confirmation analysis has increased over the last several years. It can be expected that this trend will continue because the low sample volumes make simultaneous detection of different drug classes with limited sample preparation necessary. Literature on proficiency testing to ensure reliability and comparability of results is limited.

Oral fluid has become an important sample type in driving under the influence research, and the first legal random drug testing program in oral fluid since 2004 has been organized in Victoria. It can be expected that the role of oral fluid as an alternative matrix will keep increasing in the future.}},
  author       = {{Pil, Kristof and Verstraete, Alain}},
  issn         = {{0163-4356}},
  journal      = {{THERAPEUTIC DRUG MONITORING}},
  keywords     = {{IMPAIRMENT SYMPTOMS,QUANTITATIVE-ANALYSIS,ENANTIOSELECTIVE MEASUREMENT,DELTA(9)-TETRAHYDROCANNABINOL THC,WHOLE-BLOOD,ILLICIT DRUGS,COLLECTION DEVICE,SOLID-PHASE EXTRACTION,METABOLITE 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID,liquid chromatography,TANDEM MASS-SPECTROMETRY,high-pressure,narcotics,saliva,automobile driving}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{196--202}},
  publisher    = {{LIPPINCOTT WILLIAMS & WILKINS}},
  title        = {{Current developments in drug testing in oral fluid}},
  volume       = {{30}},
  year         = {{2008}},
}

Web of Science
Times cited: